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Abstract. Interaction of cyclodextrins (CDs) with the two most abundant proteins, namely human serum
albumin (HSA) and bovine serum albumin (BSA), has been investigated using steady-state and time-resolved
fluorometric techniques, circular dichroism measurements and molecular docking simulation. The study reveals
that the three CDs interact differently on the fluorescence and fluorescence lifetimes of the serum albumins.
However, fluorescence anisotropy and circular dichroism are not affected. Depending on their size, different
CDs bind to the serum albumins in different positions, resulting in changes in the spectral behaviour of the
proteins. Docking study suggests the probable binding sites of the three CDs with the proteins. Combined
experimental and computational studies imply that sufficiently high concentration of CDs causes loosening of
the rigid structures of these transport proteins, although their secondary structures remain intact. Thus, CDs are
found to be safe for the serum proteins from the structural point of view.
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1. Introduction
Serum albumins, abundant in blood plasma, are among
the most widely studied proteins. Structural aspects
and properties of these transport proteins have been
well explored. The primary structure of these transport
proteins has about 580 amino acid residues and is char-
acterized by a low content of tryptophan and a high
content of cystine stabilizing a series of nine loops. The
secondary structures of these serum albumins are con-
stituted of ∼67% of helix of 6 turns and 17 disulfide
bridges.1,2 The tertiary structure is composed of three
domains, I, II, and III. Each domain is constituted of
two sub-domains named A and B.1,2 Since domains II
and III share a common interface, binding of a probe
to domain III leads to conformational changes affect-
ing the binding affinities to domain II and vice versa.
Human and bovine serum albumins (HSA and BSA)
display approximately 80% sequence homology and a
repeating pattern of disulfides, which are strictly con-
served. From the spectroscopic point of view, one of the
main differences between the two proteins is that HSA
has only one tryptophan residue (Trp-214), whereas
BSA has two tryptophan residues (Trp-134 and Trp-
212) at different locations.1,2 From the crystallographic
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structure of HSA, it is proposed that in this protein the
single tryptophan residue (Trp-214) is located in the
sub-domain IIA consisting of the Lys(212)-Ala(213)-
Trp(214)-Ala(215)-Val(216)-Ala(217)-Arg(218) chain
of the amino acid. In case of BSA, Trp-212 is located
in a similar microenvironment of sub-domain IIA as
the single Trp-214 in HSA, but Trp-134 is found to
be localized in the second helix of the sub-domain IB,
and buried in a hydrophobic pocket.2 However, this
assembling of the domains can be modified, depend-
ing on the environmental conditions. Helms et al. and
El-Kemary et al. have suggested that the serum proteins
can adopt many conformations, ranging from a com-
pact structure to a relaxed form.3,4 Albumins have been
identified as major transport proteins in blood plasma
for many compounds like drugs, fatty acids, hormones,
etc. Drugs and other bioactive small molecules can bind
reversibly to albumins, whereby the latter serve as car-
rier. Furthermore, albumins are the biomacromolecules
that are involved in the maintenance of colloid–blood
pressure and are implicated in facilitating transfer of
many ligands across the organ–circulatory interfaces
such as liver, intestine, kidney and brain.5 Fluorescence-
probe spectroscopy of proteins is one of the most pow-
erful methodologies, yielding structural and dynamical
information concerning the fluorophore environment.
Since long, excited-state photophysics has been known
to be exploited to explore the interaction between a
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fluorescent probe and its environment.6–10 The struc-
tures of HSA and BSA are given in scheme 1 showing
different domains, sub-domains and the locations of the
tryptophan units.
Cyclodextrins (CDs) are made up of glucopyranose
units bound together in a ring forming a cone-shaped
structure. The most common are α-, β- and γ -CDs
containing 6, 7 and 8 sugar units, respectively, linked
through α-(1,4)-glycosidic bonds. Cyclodextrins can be
topologically represented as toroids with a hydrophilic
exterior and semi-polar interior cavity,11–13 the larger
and the smaller openings of the toroid exposing sec-
ondary and primary hydroxyl groups, respectively, to
the protic solvent. The interior of the toroids is not
entirely hydrophobic but considerably less hydrophilic
than aqueous environment, enabling them to host other
hydrophobic molecules. In contrast, the exterior is
sufficiently hydrophilic to impart water solubility to
CDs. These two effects together lead to the forma-
tion of supramolecular host–guest inclusion complexes
with a verity of hydrophobic molecules, involving non-
covalent interactions in aqueous environment.14 Thus,
through CD complexation, it is possible to enhance the
aqueous solubility and drug bioavailability after oral
administration. The structures and dimensions of the
three CDs are presented in scheme 2.
CDs are often used as vehicles of many drugs for safe
and targeted delivery. However, an important aspect has
remained unattended. We have to ensure that addition
of CDs does not affect the stability and structure of the
transport proteins such as HSA and BSA in the blood
stream. With this objective, in the present work, we
have investigated the interaction of the serum albumins
with CDs to see if there is a structural deformation of
the albumin proteins upon addition of the CDs.
2. Experimental
2.1 Materials
HSA and BSA (Sigma, USA) and Tris–HCl buffer
(Spectrochem, India) were used as received. As much as
1 × 10−2 mol dm−3 buffer solution was prepared and its
pH was adjusted to 7.4. Stock solutions of 2 × 10−3 mol
dm−3 of both HSA and BSA proteins were prepared in
this buffer. The same buffer solution was used as bulk
medium throughout the study. α-, β- and γ -CDs (Fluka,
USA) were used as received without further purifica-
tion. AR-grade potassium iodide was purchased from
Merck, India. Triply distilled water was used through-
out the study. In all the experiments, protein concen-
trations were kept at 3.5 × 10−6 mol dm−3 and 2.5 ×
10−6 mol dm−3 for HSA and BSA, respectively, except
circular dichroism experiment where protein concentra-
tions (for both HSA and BSA) were kept at a much
lower value (0.15 × 10−6 mol dm−3) to match with the
instrumental criterion.
2.2 Methods
Shimadzu UV-2450 absorption spectrophotometer was
used for the steady-state absorption studies. Steady-
state fluorescence measurements were performed with
a Horiba Jobin Yvon Fluoromax-4 spectrofluorom-
eter. Measurements of the steady-state fluorescence
anisotropy were made using the same spectrofluorome-
ter. Fluorescence anisotropy (r) is defined as
r = (IV V − G.IV H ) / (IV V + 2G.IV H ) (1)
where IV V and IV H are the emission intensities obtained
with the excitation polarizer oriented vertically and
Scheme 1. Structures of (a) human serum albumin and (b) bovine serum albumin.
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Scheme 2. Structures and dimensions of the three cyclodextrins.
emission polarizer oriented vertically and horizontally,
respectively. The G factor is defined as15
G = IHV /IHH (2)
where the intensities IHV and IHH refer to the vertical
and horizontal positions of the emission polarizer, with
the excitation polarizer being horizontal. Fluorescence
lifetimes were determined from the time-resolved fluo-
rescence decays by the method of time-correlated sin-
gle photon counting (TCSPC) using excitation source at
295 nm (NanoLED) with TBX-04 detector (both IBH,
UK). The instrument response time was ∼1 ns. The
instrument response function was collected by placing
a scatterer (dilute micellar solution of sodium dodecyl
sulfate in water) in place of the sample. The decays
were analyzed using IBH DAS-6 decay analysis soft-
ware. Goodness of the fits was evaluated from the
χ 2criterion and visual inspection of the randomness of
the residuals of the fitted function to the data. Mean
(average) fluorescence lifetimes (τavg) for biexponential
decays were calculated from the decay times (τ1 and τ2)
and the normalized pre-exponential factors (a1 and a2)
using the following relation:
τavg = a1τ1 + a2τ2 (3)
Circular dichroism spectra were recorded on a JASCO
J-815 spectropolarimeter using a rectangular quartz
cuvette of path length 1 cm. The circular dichro-
ism profiles were obtained employing a scan speed of
50 nm/min and appropriate baseline corrections were
made. All the experiments were performed at room
temperature (300 K) with air-equilibrated solutions.
For molecular docking simulation, the crystal struc-
tures of the CDs were obtained from the Protein
Data Bank having PDB Codes: 2ZYM,16 2Y4 S17 and
2ZYK18 for α-CD, β-CD, and γ -CD respectively. The
native structure of HSA was taken from the Protein
Data Bank having PDB Code: 1AO6.19 Docking sim-
ulation was performed with the AutoDock 4.2 suite
of programs20 which utilizes the Lamarckian Genetic
Algorithm (LGA). The grid size was set to 126, 126 and
126 along X-, Y- and Z-axis with 0.414 Å grid spac-
ing. To obtain an unbiased result, blind docking simula-
tion was performed. The AutoDocking parameters used
were as follows: GA population size = 150; maximum
number of energy evaluations = 250000; GA crossover
mode = two points. The PyMOL software package was
used for visualization of the docked conformations.21
3. Results and discussion
3.1 Steady-state absorption study
Buffered aqueous solution of HSA gives an absorption
spectrum with a band maximum at 280 nm.22 Addi-
tion of CDs to the solution results in an increase in
the absorbance without any appreciable shift in the
absorption maximum. In all the cases, an additional lit-
tle red shifted band is observed to be formed, peak-
ing at around 325 nm. We assign this band to the
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HSA–CD complex. The intensity of this new absorption
band, however, varies with a change in the CD. Simi-
larly, addition of CDs to the aqueous buffered solution
of BSA causes increase in absorbance with no appre-
ciable change in the position of the absorption band at
280 nm.23 Here also we observe development of a new
red shifted band at around 325 nm, indicating formation
of the BSA–CD complex. Like HSA, in BSA also the
intensity of this new absorption band varies as the CD is
changed. The absorption spectral changes of HSA and
BSA with the gradual addition of α-, β- and γ -CD are
shown in figure 1.
From figure 1, it is observed that with gradual addi-
tion of CDs to the serum albumin solutions, absorbance
at ∼280 nm, ascribed to the aromatic residues24
increases. A similar enhancement in the absorbance of
the 280 nm band of BSA upon interaction with carbon
nanotubes has recently been reported by Zhao et al.25 In
tune with them we ascribe the observation to a partial
loosening of the serum albumin structure that eventu-
ally exposes the Trp residue to the relatively more polar
aqueous buffer environment.
As is obvious from figure 1, the intensities of the
new absorption bands in HSA and BSA with the addi-
tion of the three CDs do not follow any particular
order. In principle, intensity of this band is supposed
to depend on the concentration of the individual com-
plex, i.e., on the binding constant (Kb) value, as well
as its molar extinction coefficient (ε). The net intensity
should be a reflection of the product of these two. To
obtain a proper rationale to correlate the relative inten-
sities of these absorption bands, we have determined the
binding constant (Kb) as well as the molar extinc-
tion coefficient (ε) values for the complexes of serum
proteins with the CDs using the Benesi–Hildebrand
equation26 given bellow.
[SA] /OD = 1/εKb [CD] + 1/ε (4)
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Figure 1. Absorption spectra of HSA (left panel) and BSA (right panel) as a
function of (a) α-CD, (b) β-CD and (c) γ -CD concentrations.
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where [SA] and [CD] are the concentrations of the
serum proteins and cyclodextrins, respectively. OD and
ε are the optical density and molar extinction coefficient
of the protein–CD complex, respectively. From the
linear plots (figures S1 and S2 given in the Supplemen-
tary information) of the [SA]/OD against 1/[CD], Kb
values are determined from the ratios of the intercepts
to the slopes and ε values are obtained from the recipro-
cal of the intercepts. From the calculated Kb values we
have determined the values of the free energy changes
(G) for the CD complexation process by using the
well-known equation (eq. 5) given below.
G = −RTlnKb (5)
Negative G values imply that in all the cases the com-
plexation processes are spontaneous. Values of Kb, G
and ε for all the cases are collected in table 1.
The absorption spectral changes of the serum pro-
teins with the gradual addition of CDs can now be
well explained considering the values of Kb and ε. As
expected, intensities of the new absorption bands are
found to follow the order of the values of the product
of Kb and ε (table 1 and figure 1). Though the Kb value
for HSA–α-CD complex is higher than the other two
CDs, ε value of this complex is reasonably low com-
pared to the ε values of HSA–β-CD and HSA–γ -CD
complexes. The highest intensity of the absorption band
of the HSA–β-CD complex (at ∼325 nm) is rationa-
lized from the highest value of the product of Kb and ε
in case of complexation of HSA with β-CD. In the same
way, the relative intensities of the absorption bands of
the BSA–CD complexes can be rationalized from the
product of the Kb and ε values of the individual com-
plexes. It is pertinent to mention here that we have not
considered the effect of aggregation of CDs since in
aqueous CD solutions the fraction of molecules parti-
cipating in aggregate formation is extremely low.27 For
example, the mass contribution of the α-CD-aggregates
in aqueous 12 mM α-CD solution does not exceed 0.8%
that of β-CD in 10 mM β-CD solution only 0.0011%
and that of γ -CD in 12 mM γ -CD solution only
0.02%.27
3.2 Steady-state emission study
Emission spectra of aqueous buffered solutions of HSA
and BSA show single, broad and unstructured bands
peaking at ∼345 nm and ∼350 nm, respectively.28,29
Upon addition of the CDs, fluorescence intensities of
both the proteins decrease appreciably (figure 2). In
case of both HSA and BSA the extent of quenching
follows the order: γ -CD > β-CD > α-CD. Further, we
notice a detectable bathochromic shift of the emission
maximum of HSA by 5 nm and 7 nm in β- and γ -CD,
respectively. This shift is found to be much less for
BSA (2 nm for both β- and γ -CD). For both the
proteins, however, no detectable shift in the band posi-
tions is noticed with the addition of α-CD. The rela-
tive extents of quenching of the fluorescence of HSA
and BSA in the presence of the three CDs become more
apparent when the normalized fluorescence of the pro-
tein is plotted as a function of concentration of the dif-
ferent CDs (figures S3 and S4 in the Supplementary
information).
The remarkable quenching in the fluorescence inten-
sities of serum albumins with the addition of CDs
implies an interaction between the proteins and the
CDs. It is known that fluorescence intensity of trypto-
phan (Trp) decreases with an increase in the solvent
polarity.30 Thus, the quenching and the red shift in the
emission maxima indicate that the CDs are introdu-
cing an increase in the polarity of the microenvironment
around the tryptophan moiety. As will be seen from the
docking study, CDs bind to different portions of the
serum albumins. This seems to cause different extent of
loosening of the rigid structures of the serum albumins.
As a result, the tryptophan moieties get exposed to the
aqueous phase to different extents leading to change
in the micropolarity around tryptophan and consequent
changes in the fluorometric behaviour of the serum
albumins. The difference in the extent of quenching of
the emission intensities of BSA compared to HSA is
rationalized from the consideration of the fact that HSA
contains only one tryptophan (Trp-214), whereas BSA
contains two tryptophan units (Trp-212 and Trp-134)
in different positions within itself. Trp-212 resides in
Table 1. Binding constant (Kb), free energy change (G) and molar extinction co-efficient (ε) values for complexation of
the serum proteins with cyclodextrins.
HSA BSA
Kb (mol−1 dm3) G (kJ mol−1 dm3) ε (mol−1 dm3 cm−1) Kb (mol−1 dm3) G (kJ mol−1 dm3) ε (mol−1 dm3 cm−1)
α-CD 284 −14.09 2330 185 −13.02 2500
β-CD 185 −13.02 5060 198 −13.19 3730
γ -CD 93 −11.31 3480 123 −12.00 4230
936 Saptarshi Ghosh et al.
300 350 400 450
Fl
. I
nt
en
si
ty
 (a
.u.
)
Wavelength(nm)
[  -CD ]
0mM
1mM
2mM
 3mM
 5mM
7mM
 10mM
13mM
16mM
19mM
22mM
25mM
 28mM
 31mM
 34mM
300 350 400 450
[ -CD]
  0 mM
  1 mM
  2mM
  3 mM
  5 mM
  10 mM
  16 mM
  22 mM
  28 mM
  31 mMFl
. I
nt
en
si
ty
 (a
.u.
)
Wavelength (nm)
300 350 400 450
Fl
. I
nt
en
si
ty
 (a
.u.
)
Wavelength (nm)
  1mM 
2mM  
3mM 
4mM 
5mM 
6mM 
7mM 
8mM 
9mM 
10mM 
11mM 
12mM 
13mM 
14mM 
15mM 
-CD ]
300 350 400 450
[ -CD]
  0 mM
  1 mM
  2 mM
  3 mM
  4 mM
  5 mM
  7 mM
  8 mM
  9 mM
  11 mM
  13 mM
  15 mMFl
. I
nt
en
si
ty
 (a
.u.
)
Wavelength (nm)
300 350 400 450
Fl
. I
nt
en
si
ty
 (a
.u.
)
Wavelength (nm)
   0mM
1mM 
2mM 
3mM 
4mM 
5mM 
6mM 
7mM 
8mM 
9mM 
10mM 
11mM 
12mM 
13mM 
15mM 
17mM 
19mM 
-CD ]
300 350 400 450
[ -CD ]
  0 mM
  1 mM
  3 mM
  5 mM
  6 mM
  8 mM
  10 mM
  13 mM
  15 mM
 17 mM
 18 mM
 20 mM
 22 mM
 24 mM
 26 mM
Fl
. I
nt
en
si
ty
 (a
.u.
)
Wavelength (nm)
(a) (a)
(b) (b)
(c) (c)
Figure 2. Variation of emission spectra of HSA (left panel) and BSA
(right panel) as a function of (a) α-CD, (b) β-CD and (c) γ -CD concentration.
λexc = 280 nm. The concentrations of CDs are labelled in the legends.
sub-domain IIA in BSA similar to that of Trp-214 in
HSA. The other tryptophan of BSA, i.e., Trp-134, is
located in the sub-domain IB. Similar nature of quen-
ching of both HSA and BSA in different CDs indi-
cate that quenching in the emission intensities of
serum albumins by CD-complexation occurs due to
the change in the micropolarity around the trypto-
phan moiety that resides in the similar environment
(Trp-214 in HSA and Trp-212 in BSA). It appears
from the experiments that Trp-134 does not report to
the addition of CDs and, hence introduces in a sense,
a dilution effect to the overall reduction in the fluo-
rescence intensity of the system with the addition of
the CDs. Hence, we observe less quenching of fluores-
cence intensity with the introduction of CDs in case of
BSA.
3.3 Time-resolved decay measurements
Fluorescence lifetime serves as a sensitive parameter
for sensing the local environment around a fluorophore,
and it is sensitive to the interactions in the photo-excited
state.31 It also allows one to understand the interac-
tion between probe and proteins.32 Despite the fact that
the structure of HSA is rather complicated, it has been
widely studied by making use of the single Trp-214
residue enabling the serum protein to act as an intrin-
sic fluorophore. In aqueous solution at neutral pH, Trp-
214 exhibits multiple exponential decays, attributed
to the existence of rotational conformational isomers,
called rotamers.15 In the present work, we have stud-
ied the effect of addition of CDs to a buffered solution
of HSA by measuring the lifetimes of Trp-214 under
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various concentrations of CDs. Depending on the avai-
lable excitation source, for lifetime measurements the
samples are excited at 295 nm and the fluorescence
decays of HSA in the absence and presence of different
CDs are monitored at the respective emission maxima.
Figure 3 shows representative decays of HSA in dif-
ferent environments. When aqueous buffered solution
of HSA is photo-excited at 295 nm, the decay profile
shows a biexponential pattern yielding lifetime values
of 4.5 ns (τ1) and 8.25 ns (τ2).32 With gradual addition
of the CDs the lifetime values are reduced, in confor-
mity with the quenching of the steady-state fluores-
cence intensity. Consistent with the steady-state fluoro-
metric experiment, the decrease in the lifetime values of
HSA in the three CDs are found to follow the order γ -
CD > β-CD > α-CD. Similarly to the steady-state fluo-
rescence, the fluorescence lifetime of tryptophan is also
known to decrease with an increase in the polarity of the
medium.33 It appears that complexation of HSA with
the CDs results in the access of some water molecules
in the periphery of the fluorophore Trp-214 unit.
Aqueous buffered solution of BSA also shows a bi-
exponential decay with lifetime values 4.5 ns (τ1) and
7.5 ns (τ2).34 With gradual addition of the CDs to the
buffered solution of BSA, the values of both shorter and
longer lifetimes get reduced following the same order
as we observe for HSA, i.e., γ -CD > β-CD > α-CD.
Consistent with the steady-state emission study, here
also we observe lesser extent of decrease in the lifetime
values than in case of HSA. This can be rationalized
by the dilution effect coming from the extra tryptophan,
i.e., Trp-134 of BSA, which is hardly affected by the
action of the CDs, as discussed earlier.
The analyzed fluorescence lifetime data of both the
albumins in the presence of varying concentrations of
α-, β- and γ -CDs are collected in tables S1–S6 (given
in the Supplementary information). The normalized
lifetime values (τ1and τ2) of HSA in presence of vary-
ing concentrations of the CDs are plotted (figure 4) for
better understanding. A similar figure (figure S5) for
BSA is provided in the Supplementary information.
Time-resolved studies, thus, corroborate the results
of the steady-state studies and hence strengthen the
proposition that introduction of the CDs to the serum
albumins causes formation of CD–protein complex,
resulting in loosening of the protein structures that
allows some of the water molecules to come to the
near vicinity of the responsible tryptophan moiety. So,
the microenvironment around the tryptophan becomes
more polar than it was before the introduction of the
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Figure 3. Time-resolved fluorescence decays of HSA in (a) α-CD, (b) β-CD and (c) γ -CD
(λexc = 295 nm). The sharp profiles on the left are the lamp profiles. Fitted lines to the decay
data are omitted in (A) and (B) to avoid clumsiness of the figures.
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(a) (b)
Figure 4. Variation of normalized shorter lifetime (a) and longer lifetime (b)
components of HSA in three CDs. λexc = 295 nm.
CDs. As we see from the steady-state and time-resolved
studies for both the proteins, effect of three CDs is
not same, which is expected from the difference in
the dimensions of the CDs. Depending on the dimen-
sions of the openings of the CDs, they bind to different
portions of the serum albumins, exerting differential
effects. This provokes us to find out the probable
location of binding of the three CDs from molecular
docking study to be described in a forthcoming section.
3.4 Steady-state fluorescence quenching study
Steady-state quenching experiment is an important
tool in fluorescence spectroscopy to understand the
degree of exposure of the fluorophore towards aque-
ous phase.35,36 To substantiate whether or not the CDs
are forcing the tryptophan moiety in the serum albu-
mins to be exposed more to the aqueous phase, we
have performed steady-state quenching studies using
KI as a quencher. We have done the experiment in the
absence and in the presence of β-CD only to look at
the changes in the value of the Stern-Volmer constant
(KSV) that indicates the degree of exposure of the fluo-
rophore to the quencher. Larger the value of KSV, higher
the degree of exposure. Stern-Volmer constants (KSVs)
can be determined from the slopes of the plots of F0/F
against concentration of the quencher.15
F0/F = 1 + KSV [Q] (6)
where F0 and F are the fluorescence intensities in the
absence and in the presence of the quencher, respec-
tively, and [Q] is the quencher concentration. Interest-
ingly, for neither of the two serum albumins we get a
linear Stern-Volmer plot (figure 5). This non-linearity
of the Stern-Volmer plot is ascribed to the biphasic
quenching of tryptophan by the quencher.37–40 The first
phase of quenching is ascribed to quenching by the
iodide ions that originally resides near the tryptophan
(quasi-static quenching), whereas the second phase is
due to quenching by free diffusing iodide ions (dynamic
quenching). In tune with Möller and Denicola,37 we
have used the modified Stern-Volmer equation to tackle
with the biphasic quenching.
F0/ (F0 − F) =
(
F0/F
′
0
)
(1/KSV [Q]) +
(
F0/F
′
0
) (7)
From the linear plot of F0/(F0 – F) against 1/[Q]
(figure 6), KSV values are obtained from the ratios of the
intercepts to the slopes and are tabulated in table 2.
Similar observations in the quenching study for both
the serum albumins suggest that the tryptophans, which
are in similar environment in the two serum albumins
(Trp-214 of HSA and Trp-212 of BSA), are involved
in the quenching process. The second tryptophan in
BSA, i.e., Trp-134, remains unaffected by the quencher,
which is consistent with the observation by Möller and
Denicola.37
The quenching constant values of the serum albumins
in the presence of β-CD are slightly higher than those
in its absence. The higher KSV values in the presence
of CD indicate that with the introduction of β-CD, the
tryptophan moieties (Trp-214 of HSA and Trp-212 of
BSA) of the serum albumins get exposed to the aqueous
phase, although only partially.
3.5 Steady-state fluorescence anisotropy study
With an objective to check whether the interaction of
the serum proteins with the CDs leads to a reduction in
the restriction on the rotational motion of the tryptophan
or not we have performed the steady-state fluorescence
anisotropy study.41 Fluorescence anisotropy reflects the
extent of restriction imposed by the microenvironment
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(a) (b)
Figure 5. Stern-Volmer plots for the fluorescence quenching of tryptophan in (A)
HSA and (B) BSA in the absence and presence of 10 mM β-CD.
on the dynamic properties of the probe, and hence
can be exploited in assessing the motional informa-
tion of the probe in various microheterogeneous envi-
ronments. An increase in the fluorescence anisotropy
signifies an increase in the motional restriction on the
probe and therefore indicates an increase in the rigidity
of the surrounding environment. We have monitored
the steady-state fluorescence anisotropy of tryptophan
residues of HSA and BSA as a function of concentra-
tion of different CDs to check whether the CDs encap-
sulate the tryptophan units of the serum albumins within
the hydrophobic cavities or not. If CDs encapsulate the
tryptophan unit within the cavities, we would expect an
increase in the anisotropy value since in that case tryp-
tophan unit will face a more constrained environment.
But we observe inappreciable change in the anisotropy
values of both the serum albumins in the presence of all
the CDs (figure 7).
It is pertinent to mention here that even in the absence
of the CDs the fluorescence anisotropies of both HSA
Figure 6. Modified Stern-Volmer plot for quenching of
fluorescence of HSA and BSA in absence and presence of
10 mM β-CD.
and BSA are found to be rather high. The higher
fluorescence anisotropy values (0.10 and 0.085 for HSA
and BSA, respectively) of tryptophan in the proteins can
be attributed to the compact structure of the proteins
encompassing the tryptophan/s imparting restriction on
its/their rotational motion. The steady-state anisotropy
measurements, however, reveal that the CDs neither
impose any motional restriction on the tryptophan moi-
ety of the serum albumins nor induce any reduction
in the restriction, already present in the proteins. This
implies that neither are the tryptophan units incorpo-
rated into the cavities of the CDs nor are the structure
of the proteins loosened to an extent to impart more
rotational freedom to the tryptophan moieties in the
presence of the CDs. However, absorption and steady-
state and time-resolved fluorometric studies definitely
establish an interaction between the CDs and the serum
albumins. Thus, it seems that CDs bind to the serum
albumins at positions away from the tryptophan units,
which appears reasonable since serum albumins, being
macromolecules, do possess multiple binding sites. The
possible binding sites of the two serum proteins are
predicted from the docking study, to be discussed later.
3.6 Circular dichroism study
Circular dichroism spectroscopy is widely used to mon-
itor the structure, conformation and stability of the
Table 2. KSV values in different media
KSV (mol−1 dm3) KSV (mol−1 dm3)
in absence of in presence of
10 mM β-CD 10 mM β-CD
HSA 113.66 121.49
BSA 41.78 45.71
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(a) (a)
(b) (b)
(c) (c)
Figure 7. Variation of fluorescence anisotropy of HSA (left panel) and BSA
(right panel) as a function of concentration of (a) α-CD, (b) β-CD and
(c) γ -CD.
proteins.42–44 It probes the secondary structure of pro-
teins although it does not provide the details regard-
ing the precise structure. Fluorescence techniques are
rather more sensitive in deciphering small changes at
molecular level.28 To decipher the structural and con-
formational changes, if any, brought in by the added
cyclodextrins, we have performed the circular dichro-
ism spectral studies of the serum albumins in the pres-
ence of varying concentrations of the three cyclodex-
trins. It is evident from figure 8 that the circular dichro-
ism spectra of HSA and BSA show two minima at
208 and 222 nm, which is a signature of the pres-
ence of α-helix in the proteins under study.42–44 As
already stated, due to the instrumental restriction we
had to take lesser concentrations of the serum pro-
teins for the circular dichroism study, as compared to
the concentrations used for the other studies. Keeping
parity with the relative concentrations of the albumins
to CDs, here we have added lesser amounts of CDs.
Addition of different CDs is found to cause impercep-
tible change in the circular dichroism spectrum of the
serum proteins, which implies that CDs are not affec-
ting the secondary structure of the serum albumins to
a detectable level. It is clear from the circular dichro-
ism spectra that CDs are not altering the protein struc-
tures as much to be probed by circular dichroism
spectroscopy. This implies that CDs cannot pene-
trate inside the serum albumins. Rather, they bind to
the surface of the proteins. Steady-state fluorescence
anisotropy study also reveals that tryptophans in the
proteins do not get encapsulated inside the nanocav-
ities of the CDs, consistent with the results obtained
from the circular dichroism spectroscopy. This confirms
that CDs are unable to change the conformation of the
serum proteins to an extent to leave a signature on their
circular dichroism spectra. This seems rational from the
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(a) (a)
(b) (b)
(c) (c)
Figure 8. Circular dichroism spectra of HSA (left panel) and BSA
(right panel) as a function of concentration of (a) α-CD, (b) β-CD and (c)
γ -CD. The concentrations of CDs used are labeled in the legends.
standpoint of the structures of the serum albumins com-
posed of a single polypeptide chain. The proteins con-
tain 17 disulfide bridges, which are located at regular
intervals in the protein molecules. Thus, in addition to
the general compact folded nature of the native protein,
the flexibility of serum albumin molecules is consid-
erably restricted by these 17 disulfide bridges45 that is
also evident from the higher anisotropy values of trypto-
phan in the proteins. Hence, when CDs interact with the
serum proteins in a freely diffusing medium, the com-
pact native structures of the proteins are not expected
to be unfolded to a considerable extent. Rather, CDs
should interact, preferably, along the surface of the
proteins. Blind molecular docking simulations have
been exploited to decipher the possible locations of
binding.
3.7 Molecular modeling: Blind docking simulation
To understand the binding action of CDs to the two
albumin proteins, knowledge of proper binding loca-
tion of the CDs onto the proteins is essential. With this
objective, we have performed docking simulation study
with HSA only according to the protocol described
in section 2.2. As HSA and BSA display approxi-
mately 80% sequence homology,34 it is expected that
CDs bind to the serum albumins in similar sites. Thus,
molecular docking simulation with only HSA should be
enough to understand the binding locations of the serum
proteins. To obtain an unbiased result in this respect,
the AutoDock-based blind docking simulation has
been employed. The strategy of AutoDock-based blind
docking includes a search over the entire surface of the
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(a)
(b)
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Figure 9. Stereo view of docked conformation of (A) α-CD, (B) β-CD and (C) γ -
CD with the protein HSA. Left panel in each case displays the protein residues in near
vicinity (within 4.0 Å) of the CDs over a molecular surface presentation of the protein.
The pictures have been prepared by PyMOL software package.
protein for binding sites and simultaneously optimizing
the conformations of the peptides.20,46–48 This leads to
an unbiased result, and hence has fairly been described
as “very encouraging” in a recent review.48 The docked
results are presented in figure 9. Docking study with
human serum albumin (HSA) implies that the three dif-
ferent CDs bind to three different portions of HSA, con-
siderably away from the tryptophan moiety. Docking
study suggests that both α- and β-CD bind in the sub-
domain IIB, whereas γ -CD binds in the sub-domain
IIIA. This binding of CDs in the sub-domain IIB or
IIIA affects the spatial conformation of the tryptophan
unit located in the sub-domain IIA as domains II and
III share a common interface. The binding of CDs
with the serum albumins depends on the cavity sizes
of the CDs. The hydrophobic interaction plays a major
role in the protein–CD complexation process. Recently,
Aachmann et al. have reported a similar type of
hydrophobic interaction between protein and CD.49
They have also suggested that CDs bind to solvent-
accessible aromatic side chains on the surface of
proteins. The hydrophobic residues get encapsulated in
the cavities of the CDs, depending on the diameter of
the opening of the CD cavities, resulting in a change
in the energy landscape of the protein–CD systems,
taking it to another conformational state. The described
experiments suggest that the CD complexation causes
little loosening of the compact protein structure and
this might be the factor responsible for exposing the
tryptophan moiety more towards the aqueous phase.
4. Conclusions
The present work establishes the interactions of three
well-known cyclodextrins with two major transport pro-
teins, HSA and BSA, through vivid experimental stud-
ies as well as molecular docking simulation. Depending
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on their cavity sizes, CDs bind to these transport pro-
teins in different positions. This binding leads to a
change in the polarity around the micro-environment
of the intrinsic fluorophore of these proteins, i.e., the
tryptophan moiety. Absorption, steady-state and time-
resolved fluorometric and fluorescence quenching stud-
ies reveal that at high concentration of CDs the pro-
tein structure is loosened considerably, which, appre-
hensively, might affect the normal function of these pro-
teins. Fluorescence anisotropy and circular dichroism
studies, however, reveal insignificant structural change
induced by the CDs. Circular dichroism study con-
firms no detectable change in the secondary structure
of the proteins with the introduction of the CDs. Thus,
although CDs can be considered as physiologically safe
so far as their action on the serum proteins is concerned,
their use at higher concentrations might degrade the
transport ability of the serum proteins towards carrying
drugs.
Supplementary Information
Benesi–Hildebrand plots for both HSA and BSA, plot
of normalized fluorescence of the proteins against the
concentration of the different CDs, the analyzed fluo-
rescence lifetime data of both the albumins in the pres-
ence of varying concentrations of the three CDs and
variation of normalized lifetime values of BSA in the
presence of varying concentrations three CDs are pre-
sented in the Supplementary information (see www.ias.
ac.in/chemsci).
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